Projects per year
Personal profile
External positions
Partner, EQT Life Sciences
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
Testing low-dose efavirenz treatment for Alzheimer's disease: a phase 1b dosing, target-engagement and exploratory biomarker study
Scheltens, P. (Principal investigator)
Alzheimer's Drug Discovery Foundation
01/10/2021 → 30/03/2024
Project: Research
-
Harmonization and innovation of cognitive, behavioural and functional assessment in neurodegenerative dementias
Costa, A. A. (Principal investigator), Ceccaldi, M. M. (CoPI), Caffarra, P. P. (CoPI), Caltagirone, C. C. (CoPI), Cappa, S. S. (CoPI), Ti Raboschi, P. T. P. T. (CoPI), Crutch, S. S. (CoPI), Della Sala, S. S. (CoPI), Bak, T. T. (CoPI), Rossor, M. M. (CoPI), Duzel, E. E. (CoPI), Nestor, P. P. (CoPI), Scheltens, P. (CoPI), Van De Flier, W. W. (CoPI), Visser, P.-J.P.-J. (CoPI), Waldemar, G. G. (CoPI), Salmon, E. E. (CoPI), Papageorgiou, S. S. (CoPI), Dubois, B. B. (CoPI) & François Démonet, J. F. J. F. (CoPI)
EU Joint Programme – Neurodegenerative Disease Research
01/10/2014 → 31/03/2015
Project: Research
-
Functional Connectivity in Elderly Controls and Alzheimer's Patients Using Resting State fMRI: A Pilot Study
Scheltens, P. (Principal investigator)
Alzheimer's Drug Discovery Foundation
24/10/2003 → 13/01/2005
Project: Research
Research output
-
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
Cummings, J. L., Teunissen, C. E., Fiske, B. K., le Ber, I., Wildsmith, K. R., Schöll, M., Dunn, B. & Scheltens, P., 2025, (E-pub ahead of print) In: Nature reviews. Drug discovery. eabj2658.Research output: Contribution to journal › Review article › Academic › peer-review
-
Characterizing visual read tau-PET-negative participants with Alzheimer's disease dementia
Rikken, R. M., Coomans, E. M., de Koning, L. A., Visser, D., Neutelings, E., den Braber, A., Collij, L. E., Golla, S. S. V., Barkhof, F., Alzheimer's Disease Neuroimaging Initiative & for ADNI, 1 Apr 2025, In: Alzheimer s & dementia. 21, 4, e14423.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy
Wolk, D. A., Nelson, P. T., Apostolova, L., Arfanakis, K., Boyle, P. A., Carlsson, C. M., Corriveau-Lecavalier, N., Dacks, P., Dickerson, B. C., Domoto-Reilly, K., Dugger, B. N., Edelmayer, R., Fardo, D. W., Grothe, M. J., Hohman, T. J., Irwin, D. J., Jicha, G. A., Jones, D. T., Kawas, C. H. & Lee, E. B. & 17 others, , 1 Jan 2025, In: Alzheimer s & dementia. 21, 1, e14202.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Enlarged cavum septum pellucidum as a neuroimaging signature of head impact exposure
Kamps, S., Hempel, H. L., van Amerongen, S., de Bruin, H., van der Linden, F. H. C., Venkatraghavan, V., van der Flier, W. M., Pijnenburg, Y. A. L., Barkhof, F., Scheltens, P. & Alzheimer's Disease Neuroimaging Initiative (ADNI), 2025, In: Brain Communications. 7, 2, fcaf085.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease
Cummings, J. L., Atri, A., Feldman, H. H., Hansson, O., Sano, M., Knop, F. K., Johannsen, P., León, T. & Scheltens, P., Dec 2025, In: Alzheimer's Research & Therapy. 17, 1, p. 14 1 p., 14.Research output: Contribution to journal › Article › Academic › peer-review
Open Access5 Citations (Scopus)
-
Incorporating measure of heterogeneity into trial design in AD trials
Scheltens, P. (Speaker)
27 Feb 2022Activity: Talk or presentation › Invited talk › Academic
-
Subjective Cognitive Complaints
Scheltens, P. (Speaker)
5 Oct 2021Activity: Talk or presentation › Invited talk › Academic
-
Neuroimaging in dementia
Scheltens, P. (Speaker)
5 Oct 2021Activity: Talk or presentation › Invited talk › Academic
-
A path towards precision medicine in AD
Scheltens, P. (Speaker)
5 May 2021Activity: Talk or presentation › Invited talk › Academic
-
The Alzheimer's Paradox: Adcancing Criteria but Failing in Clinical Trials - What to Expect from the future
Scheltens, P. (Speaker)
23 Jan 2020Activity: Talk or presentation › Invited talk › Academic